Home Newsfeeds Jefferies Maintains Hold on Oracle, Raises Price Target to $85

Jefferies Maintains Hold on Oracle, Raises Price Target to $85

Jefferies analyst Brent Thill maintains Oracle (NYSE:ORCL) with a Hold and raises the price target from $80 to $85.

byBenzinga Newsdesk

September 13, 2022

1 minute read

Jefferies analyst Brent Thill maintains Oracle (NYSE:ORCL) with a Hold and raises the price target from $80 to $85.

Maximize Your Returns: Get To Know The Top Performing Cannabis Stocks Of The Last 12 Months

By Jelena Martinovic

March 7, 9:09 PM

The past 12 months have been a wild ride for both investors and cannabis shareholders, as evidenced by big rallies as well as steep declines.

ACRDF

Wells Fargo Initiates Coverage On Antero Resources with Overweight Rating, Announces Price Target of $34

By Benzinga Newsdesk

January 25, 6:14 AM

Wells Fargo analyst Roger Read initiates coverage on Antero Resources (NYSE:AR) with a Overweight rating and announces Price Target of $34.

Femasys’ FemCerv Endocervical Tissue Sampler For Cervical Cancer Diagnosis Receives Product Approval In Canada

By Benzinga Newsdesk

May 3, 8:40 AM

- FemCerv® is the first endocervical tissue sampler designed to collect and contain a comprehensive sample to maximize quality and quantity - ATLANTA, May 03, 2023 (GLOBE NEWSWIRE) -- Femasys Inc.

FEMY

Analyst Ratings

What Analysts Are Saying About PayPal Holdings Stock

By Benzinga Insights

January 24, 4:00 PM

In the last three months, 17 analysts have published ratings on PayPal Holdings (NASDAQ:PYPL), offering a diverse range…

PYPL

Jefferies Maintains Hold on Oracle, Raises Price Target to $85

Related Posts

Maximize Your Returns: Get To Know The Top Performing Cannabis Stocks Of The Last 12 Months

Wells Fargo Initiates Coverage On Antero Resources with Overweight Rating, Announces Price Target of $34

Femasys’ FemCerv Endocervical Tissue Sampler For Cervical Cancer Diagnosis Receives Product Approval In Canada

What Analysts Are Saying About PayPal Holdings Stock